Harvard Bioscience, Inc. (HBIO)
NASDAQ · Healthcare
Harvard Bioscience, Inc. Total Liabilities 2009–2025
Harvard Bioscience, Inc. annual total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Harvard Bioscience, Inc. total liabilities as of December 31, 2025: 66.3M, a 4.79% increase year-over-year.
- Harvard Bioscience, Inc. total liabilities for 2025 were 66.3M, a 4.79% increase from 2024.
- Harvard Bioscience, Inc. total liabilities for 2024 were 63.3M, a 1.54% decrease from 2023.
- Harvard Bioscience, Inc. total liabilities for 2023 were 64.3M, a 12.10% decrease from 2022.
- Harvard Bioscience, Inc. total liabilities for 2022 were 73.1M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Harvard Bioscience, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $66 |
| 2024 | $63 |
| 2023 | $64 |
| 2022 | $73 |
| 2021 | $79 |
| 2020 | $80 |
| 2019 | $83 |
| 2018 | $86 |
| 2017 | $28 |
| 2016 | $36 |
| 2015 | $42 |
| 2014 | $40 |
| 2013 | $41 |
| 2012 | $29 |
| 2011 | $31 |
Harvard Bioscience, Inc. Total Liabilities — FAQ
Harvard Bioscience, Inc. (HBIO) total liabilities over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see HBIO's total liabilities history?
The chart and table above show Harvard Bioscience, Inc.'s total liabilities by year and by quarter, including the growth rate.